BiotechTube

pregabalin sustained release tablet + pregabalin immediate release capsule

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Neuropathic Pain

Conditions

Neuropathic Pain, Diabetes Mellitus, Type 2

Trial Timeline

May 12, 2020 → Dec 20, 2022

NCT ID
NCT05624853

About pregabalin sustained release tablet + pregabalin immediate release capsule

pregabalin sustained release tablet + pregabalin immediate release capsule is a approved stage product being developed by Yuhan for Neuropathic Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT05624853. Target conditions include Neuropathic Pain, Diabetes Mellitus, Type 2.

What happened to similar drugs?

8 of 20 similar drugs in Neuropathic Pain were approved

Approved (8) Terminated (2) Active (12)
✅Duloxetine + Pregabalin + PlaceboShionogiApproved
✅Gabapentin/B-complex + PregabalinMerckApproved
✅CarbamazepineNovartisApproved
✅Ranolazine + PlaceboGilead SciencesApproved
✅PregabalinPfizerApproved
✅pregabalin and celecoxib + Placebo and celecoxibPfizerApproved
✅Pregabalin + PlaceboPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05624853ApprovedCompleted

Competing Products

20 competing products in Neuropathic Pain

See all competitors
ProductCompanyStageHype Score
CHF6467 activeComac MedicalPhase 1/2
22
LY3857210 + PlaceboEli LillyPhase 2
35
OK-101 0.05% + OK-101 0.1% + PlaceboOKYO PharmaPhase 2
17
YHD1119 + LyricaYuhanPhase 3
40
YHD1119 300mg + YHD1119 300mgYuhanPhase 1
29
DS-5565 + placeboDaiichi SankyoPhase 3
40
Mirogabalin + PlaceboDaiichi SankyoPhase 3
40
DS-1971a + placebo + pregabalinDaiichi SankyoPhase 2
27
DS-5565Daiichi SankyoPhase 3
40
Placebo + MirogabalinDaiichi SankyoPhase 3
40
QutenzaAstellas PharmaPre-clinical
26
Qutenza exposureAstellas PharmaPre-clinical
26
Duloxetine + Pregabalin + PlaceboShionogiApproved
43
LY3016859 + PlaceboEli LillyPhase 2
35
LY3556050 + PlaceboEli LillyPhase 2
27
LY3526318 + PlaceboEli LillyPhase 2
35
LY4065967 + PlaceboEli LillyPhase 2
42
LY3848575 + PlaceboEli LillyPhase 2
39
ABT-639 + pregabalin + PlaceboAbbViePhase 2
35
onabotulinum toxin AAbbViePhase 2
35